X4P-001 (Mavorixafor)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for X4P-001 (Mavorixafor), covering 2024-10-30 to 2024-10-30. Get the full timeline:
Most recent: Clinical Trial Update: A Dose Determination and Safety Study of X4P-001 (Mavorixafor) in Participants With Warts, Hypogammaglobulinemia, Infections, and Myelokathexis (WHIM) Syndrome [Phase 2]